Authors: Shaamash, A.H.¹; Zakhari, M.M.²

Source: Human Reproduction, Volume 20, Number 1, 1 January 2005 , pp. 302-306(5)

Publisher: Oxford University Press

Abstract:

BACKGROUND: Nitric oxide (NO) is a potent angiogenic and vasodilator factor that could be involved in progestin-induced bleeding. This study aimed to assess possible changes in the serum levels of NO metabolites in progestin-only contraceptive users and to identify any correlation between some of their clinical characteristics and NO metabolite levels. METHODS: This cross-sectional study included 37 contraceptive users; a single 5 ml venous blood was collected at different periods of contraceptive use. Women were divided into users with acceptable menstrual bleeding (n=13) and those having abnormal bleeding patterns (n=24). The controls are 13 age-matched healthy women; they were fertile, had regular menstruation and did not use any contraceptive method in the previous 3 months. NO was determined by the evaluation of its oxidation products (nitrites and nitrates) where the nitrates were reduced to nitrites with cadmium filings; total serum concentrations of nitrites were measured by using the Griess reaction. RESULTS: The mean serum levels of NO metabolites were significantly higher in the contraceptive users than in the controls (mean±SE) 34.9±11.3 versus 6.1±1.5 mol/l (P<0.000). The mean serum levels of NO metabolites were significantly higher in the contraceptive users with abnormal bleeding patterns than in those with normal bleeding patterns (mean±SE) 41.3±7.4 versus 23.2±5.8 mol/l (P<0.000). There was a positive correlation between NO levels and both prolonged spotting and heavy/prolonged bleeding days (P<0.001 and P<0.01, respectively) and negative correlation between NO levels with the duration of use and length of the menstrual cycle (P<0.05). CONCLUSION: The significantly increased serum levels of NO metabolites among contraceptive users may primarily reflect an increase in its endometrial production, possibly secondary to its increased liberation by systemic vascular endothelium.This may result in enhanced endometrial angiogenesis and vascular dilatation which can induce and perpetuate abnormal excessive/prolonged uterine bleeding.

Keywords: abnormal bleeding; progestin-only contraceptive; serum NO metabolites

Document Type: Research article

DOI: http://dx.doi.org/10.1093/humrep/deh541

Affiliations: 1: Departments of Obstetrics and Gynecology and 2: Biochemistry, Faculty of Medicine, Assiut University, Egypt

Publication date: 2005-01-01

More about this publication?

• Human Reproduction features full-length, peer-reviewed papers reporting original research, clinical case histories, as well as opinions and debates on topical issues. Papers published cover the scientific and medical aspects of reproductive physiology and pathology, endocrinology, andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, pregnancy, genetics, genetic diagnosis, oncology, infectious disease, surgery, contraception, infertility treatment, psychology, ethics and social issues. The highest scientific and editorial standard is maintained throughout the journal along with a rapid rate of publication.

Related content

• In this: publication
• By this: publisher
• In this Subject: Anatomy & Physiology ,  Obstetrics & Gynecology
• By this author: Shaamash, A.H. ;  Zakhari, M.M.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers